WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT

WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT

Saved in:

Bibliographic Details
Main Authors:	Briana Ndife, Carolina Aldworth, Kathleen P. Murphy, Jennifer Nguyen, Irina Pivneva, Marie Louise Edwards, Annika Anderson, James Signorovitch, Pietro Canetta
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924005886
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-551 CKD PROGRESSION IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT
by: Briana Ndife, et al.
Published: (2024-04-01)

WCN24-1680 PREVALENCE AND CLINICAL CHARACTERISTICS OF KIDNEY TRANSPLANTS IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS: RESULTS FROM A REAL-WORLD, MULTI-COUNTRY SURVEY
by: Richard Lafayette, et al.
Published: (2024-04-01)

WCN24-1688 SELF-REPORTED QUALITY OF LIFE IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS DELINEATED BY CKD STAGE: A REAL-WORLD, MULTI-COUNTRY SURVEY
by: Richard Lafayette, et al.
Published: (2024-04-01)

WCN24-478 IDENTIFYING OPPORTUNITIES TO IMPROVE EVALUATION FOR HEMATURIA IN A LARGE HEALTH SYSTEM
by: Alexander Chang, et al.
Published: (2024-04-01)

WCN25-1260 CLINICAL MANIFESTATIONS, MORPHOLOGICAL PATTERN AND TREATMENT OUTCOMES OF COMPLEMENT 3 GLOMERULOPATHY ON LONG TERM
by: Nidhi Gupta, et al.
Published: (2025-02-01)

WCN24-1400 RESPONSE TO THE TREATMENT WITH RITUXIMAB IN PATIENTS WITH GLOMERULOPATHY
by: Maria Emilia Guerrero, et al.
Published: (2024-04-01)

Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy
by: Jill J. Hauer, et al.
Published: (2024-02-01)

Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy
by: Andrew S. Bomback, et al.
Published: (2025-01-01)

WCN24-104 CLUSTERIN KNOCKOUT MICE: AN EXPERIMENTAL MODEL OF IMMUNOTACTOID GLOMERULOPATHY?
by: XINGLAN LI, et al.
Published: (2024-04-01)

WCN24-105 CLUSTERIN KNOCKOUT MICE: AN EXPERIMENTAL MODEL OF IMMUNOTACTOID GLOMERULOPATHY?
by: XINGLAN LI, et al.
Published: (2024-04-01)

WCN24-1436 COLLAPSING LUPUS PODOCYTOPATHY, UNLIKE OTHER COLLAPSING GLOMERULOPATHIES?
by: Elisa Mendoza, et al.
Published: (2024-04-01)

Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy
by: Amanda K. Slagle, et al.
Published: (2025-05-01)

P479: PIK3CA-related overgrowth syndrome: To exome or not?
by: Moon Ley Tung, et al.
Published: (2025-01-01)

WCN24-1985 CARDIAC FAILURE IN FIBRILLARY GLOMERULOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Carina Zapata, et al.
Published: (2024-04-01)

WCN24-1991 CARDIAC FAILURE IN FIBRILLARY GLOMERULOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Carina Zapata, et al.
Published: (2024-04-01)

WCN24-2435 CLINICAL CHARACTERISTICS OF PATIENTS WITH C3 GLOMERULOPATHY AND IDIOPATHIC MEMBRANOPROLIFERATIVE IMMUNE COMPLEX GLOMERULONEPHRITIS IN A HOSPITAL IN ARGENTINA
by: Lucas Ramos, et al.
Published: (2024-04-01)

WCN25-2675 C3 GLOMERULOPATHY RARE DISEASE AND NEW THERAPUTIC APPROACH
by: Emad Khater, et al.
Published: (2025-02-01)

WCN24-1394 PREGNANCY IN PATIENTS WITH PRIMARY AND SECONDARY GLOMERULOPATHIES: DIFFERENCE IN FETAL AND MATERNAL OUTCOMES
by: Ricardo Ibarra Valenzuela, et al.
Published: (2024-04-01)

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
by: Mieke van Schaik, et al.
Published: (2024-06-01)

Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis
by: Andrew S. Bomback, et al.
Published: (2025-01-01)

WCN24-1801 A RARE CASE OF COLLAGENOFIBROTIC GLOMERULOPATHY IN A 56 YEAR OLD MALE
by: Simran Sawhney, et al.
Published: (2024-04-01)

WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
by: Lucia Quintana-Gallardo, et al.
Published: (2024-04-01)

WCN24-1839 REAL-WORLD USEFULNESS OF KIDNEY FAILURE RISK EQUATION IN ADULTS WITH BIOPSY-PROVEN GLOMERULOPATHIES
by: Cristina Căpușă, et al.
Published: (2024-04-01)

WCN24-601 CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF GLOMERULOPATHIES IN TERTIARY HOSPITAL CENTERS IN RIO GRANDE DO SUL
by: Raphael Palma, et al.
Published: (2024-04-01)

C3 Glomerulopathy: Novel Treatment Paradigms
by: Blanca Tarragon Estebanez, et al.
Published: (2024-03-01)

C3 glomerulopathy is highly prevalent in French Polynesia
by: Nelly Candela, et al.
Published: (2024-12-01)

479 Effects of extracellular matrix on pacemaking cardiomyocyte function
by: Brian Howard, et al.
Published: (2025-04-01)

WCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
by: Carla Nester, et al.
Published: (2025-02-01)

WCN25-1407 INCIDENCE, RISK FACTORS AND OUTCOME OF TRANSPLANT GLOMERULOPATHY
by: EBY MATHEW, et al.
Published: (2025-02-01)

C3 Glomerulopathy: A Current Perspective in an Evolving Landscape
by: Eric Keoni Magliulo, et al.
Published: (2024-10-01)

The Role of von Willebrand Factor in the Pathogenesis of C3 Glomerulopathy
by: Zixin Hua, et al.
Published: (2025-06-01)

Pregnancy outcomes in C3 glomerulopathy: a retrospective review
by: Lauren O. Fergus, et al.
Published: (2025-05-01)

WCN24-2673 COMPLEMENT LEVELS AND PROTEINURIA IN LUPUS NEPHRITIS CORRELATIONS AND TREATMENT RESPONSE
by: Maria Izabel de Holanda, et al.
Published: (2024-04-01)

Digital Ischemia as a Rare Manifestation of C3 Glomerulopathy Associated With Monoclonal Gammopathy
by: Alistair Baber, et al.
Published: (2024-03-01)

WCN24-912 IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY
by: Jonathan Barratt, et al.
Published: (2024-04-01)

WCN25-2287 LIPOPROTEIN GLOMERULOPATHY WITH NOVEL GENETIC VARIANT- CASE REPORT
by: ananth rao konapur, et al.
Published: (2025-02-01)

WCN25-2910 Unraveling the Collapse: Outcomes of Collapsing Glomerulopathy in Renal Transplants
by: Majibullah Ansari, et al.
Published: (2025-02-01)

WCN25-4582 COLLAPSING GLOMERULOPATHY- MICROSCOPY ON AUTOPSY TISSUE AN ENRICHING EXPERIENCE
by: Ritambhra Nada DUSEJA, et al.
Published: (2025-02-01)

Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy
by: Carla M. Nester, et al.
Published: (2025-02-01)

C3 glomerulopathy triggered by infection-A rare case report
by: Diksha Samsukha, et al.
Published: (2025-08-01)